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Purpose: To identify the genetic mutation associated with distinct cases of open-angle glaucoma noted in a Chinese
family.
Methods: Clinical examination and pedigree analysis were undertaken in a family with a large number of primary open-
angle glaucoma cases. Venous blood samples were drawn from six affected and six unaffected subjects in the family.
Genomic DNA was extracted. Linkage to the optineurin gene (OPTN) locus was not excluded. Potential mutation in OPTN
was screened by polymerase chain reaction (PCR) analysis of its exon regions and direct sequencing.
Results: A missense mutation, A1274G, in exon 10 of OPTN was identified in affected patients of the family. The
corresponding amino acid change was Lys322Glu. This mutation was not found in unaffected family members of the
family or in 87 unrelated normal controls.
Conclusions: A novel mutation of a Lys322Glu change in OPTN is responsible for this familial case of primary open-
angle glaucoma observed in northeastern China.
Over  the  past  century,  there  has  been  increasing
awareness of a genetic predisposition in the development of
primary  open-angle  glaucoma  (POAG)  [1].  In  1997,  the
myocilin gene (MYOC), formerly referred to as the trabecular
meshwork-induced glucocorticoid response protein (TIGR),
was mapped to 1q, the locus associated with juvenile open-
angle glaucoma [2]. In 2002, mutations in the optineurin gene
(OPTN) were found in a large British pedigree with autosomal
dominant normal tension glaucoma (NTG). At the present
time, more than 20 distinct mutations have been found in the
OPTN coding region, four of which, having close correlation
with POAG, are located in exons 4, 5, 6, and 16 [3]. OPTN
mutations  have  been  identified  only  in  Hong  Kong  and
Guangzhou, China [4]. In this study, we sought to analyze a
cohort of patients in northeastern China with familial POAG
for mutations in OPTN.
METHODS
Clinical evaluation: The respective patients were evaluated in
the Department of Ophthalmology at the Second Affiliated
Hospital  of  Harbin  Medicine  University(Harbin,  China).
Informed  consent  was  obtained  from  all  participants  in
accordance with the Declaration of Helsinki, and the study
Correspondence  to:  Dr.  Huiping  Yuan,  Department  of
Ophthalmology,  Second  Affiliated  Hospital  of  Harbin  Medical
University,  No.246  Xuefu  Street,  Nangang  district,  Harbin,
Heilongjiang province, 150086, China; Phone: 86-451-55969288;
FAX: 86-451-86605757; email: yuanhp@yahoo.com
was  approved  by  the  Heilongjiang  Institutional  Review
Board.
A diagnosis of POAG was made in patients if they had
the  following  criteria:  1)  at  least  one  of  their  intraocular
pressure (IOP) readings was more than 21 mmHg; 2) the
patients must have open anterior chamber and were exclusive
of secondary factors (e.g. pigmentary findings); and 3) the
presence of typical glaucomatous cupping of the optic disc
with visual field defects.
Genotyping and linkage analysis: Two microsatellite markers
closely linked to two known loci were used to perform allele-
sharing among patients in the pedigree including D10S570
and D10S191, which are linked to OPTN. The oligonucleotide
primer  sequences  were  selected  from  the  GDB  Human
Genome Database. The order and genetic distances of the
markers  were  derived  from  the  Marshfield  Database.
Microsatellites were amplified by polymerase chain reaction
(PCR)  following  standard  methods.  The  genotypes  were
obtained by silver stain and manual inspection. The pedigree
and  haplotype  was  constructed  by  Cyrillic  version  2.1
(MathStat Software; Victoria, Australia). By searching in the
NCBI database, the microsatellite marker loci, D10S570 and
D10S191, near OPTN were selected for linkage analysis in
the  family.  It  was  required  that  the  distance  between  the
microsatellite marker loci and OPTN was within a range of 2
cm and that the heterozygosity of the microsatellite marker
loci was more than 0.7. D10S570 was located 0.5 cm upstream
of OPTN, and D10S191 was located at 1.5 cm downstream of
OPTN. The microsatellite marker was amplified by the PCR
Molecular Vision 2009; 15:1649-1654 <http://www.molvis.org/molvis/v15/a176>
Received 12 June 2008 | Accepted 14 August 2009 | Published 20 August 2009
© 2009 Molecular Vision
1649method, using the primer provided by NCBI database, and
then  detected  by  PAGE.  The  data  processing  was
accomplished by the Department of Biological Information of
Harbin Medical University. Reltest and Sibpal, as parts of the
statistical  coverall  software  SGEV5.2  of  genetic
epidemiology, were used for affected relatives analysis and
slib pair linkage analysis, respectively.
Extraction of DNA—From all subjects, 3 ml of blood
was drawn with citric acid glucose solution anticoagulation.
The white cells were disassociated and proteinase K digested.
Genome  DNA  was  extracted  from  peripheral  blood
leucocytes  according  to  the  routine  method  of  phenol
chloroform  (Promega,  Beijing,  China)  and  quantitated  by
ultraviolet spectrophotometry.
Polymerase chain reaction—The primers (synthetized
by  Shangon  Company,  Shanghai,  China)  were  designed
according to the base sequence of OPTN exons 4−16 (See
Table 1). Each 25 μl PCR reaction contained 2.5 μl 10X
Buffer, 1.5 μl MgCl2, 2 μl dNTP, 0.5 μl TaqE (Shanghai
Shangon Company), 2 μl primer(10 μmol/l), and 2 μl genomic
DNA. PCR was performed on a thermal cycler with an initial
denaturation step of 10 min at 95 °C followed by 35 cycles of
94 °C for 1 min, a touchdown annealing temperature of 55–
60 °C for 1 min, and 72 °C for 1 min, and a final extension
step of 72 °C for 5 min. All PCR products were visualized
with  1.5%  gel  for  30  min  and  detected  by  ultraviolet
spectrophotometry.
Sequence analysis of PCR products—PCR products
were  sent  to  Boya  Biotechnology  Company  (Shanghai,
China)to be purified, and then two-direction sequencing was
performed using an ABI 100 sequencer (Boya Biotechnology
Company, Shanghai, China). The results of sequencing were
compared  with  the  GenBank  original  sequence  using
BLAST.
RESULTS
Clinical  evaluation:  The  pedigree  of  interest  was  a  six-
generation family with six affected members (Figure 1). Each
affected member showed no gender disposition. Since the
ratio of affected males to affected females was approximately
1:1,  an  autosomal  dominant  pattern  of  inheritance  was
concluded. Demographic data of 12 patients from the pedigree
are  shown  in  Table  2.  After  obtaining  written  informed
consent, blood samples (3 ml) were collected from 6 affected
and  6  unaffected  individuals  in  the  family  pedigree.  In
addition,  blood  samples  were  obtained  from  87  normal
controls patients. Each of the blood specimens then underwent
detailed investigation with the genomic DNA extracted using
a standardized protocol.
Identification of PCR amplification products and analysis of
DNA  sequence:  All  the  PCR  amplification  products  were
specific DNA straps, among which PCR products of exon 10
was 260 bp (See Figure 2). A LOD score ≥1 supports linkage
while a LOD score ≥3 affirms the linkage, and a LOD score
≤-2  demonstrates  negativing  linkage.  The  LOD  scores  at
D10S570  and  D10S191  were  2.086101  and  1.971699,
respectively,  (all  more  than  1),  indicating  that  the  region
Figure  1.  Pedigree  of  a  six-generation  family  with  six  affected
members. Blood (3 ml) was drawn from certain members (III:2, III:
7, IV:1, IV:2, IV:3, IV:4, IV:5, V:1, V:2, V:3, V:4, and V:5) of the
family. Solid squares mean male patients, open circles mean normal
females,  solid  circles  mean  female  patients,  open  squares  mean
normal  males,  arrow  means  proband,  lines  through  circles  and
squares indicate deceased.
TABLE 1. OPTN PRIMERS USED TO AMPLIFY EXONS 4 THROUGH 16.
Exon Upstream Downstream
4 5′-GTGACTTTTCCACAGGAAC-3′ 5′-GCTAAATCCTGTGCTTCC-3′
5 5′-GGTCAAGTGGACTAGAGGGAG-3′ 5′-CTAGGAGTCTAGACACGTAAG-3′
6 5′-GCGATTAAGGGCATGAGCCC-3′ 5′-GTTTCATCTTTCCAGGGGAGG-3′
7 5′-CTTTTGACAAAGAATTTGTCTTGT-3′ 5′-GACCTCCGGTGACAAGCACCCA-3′
8 5′-AGCTGGTCCCAGTTATATTGGGT-3′ 5′-GTATGGTACTTAATTATATCTCAG-3′
9 5′-ATAATTGCTATTTCTCTTAAAGCC-3′ 5′-ACCCATCACAAGATTTCAATTCA-3′
10 5′-GCCTGTTTTCTCCTAAAGAGGTT-3′ 5′-TATAGTAGTATACTTTGTAAAAATG-3′
11 5′-CCTTGGGGTTTGTTTAAAAGCCA-3′ 5′-TGTATAAAAAGGCGATTCTCCC-3′
12 5′-TTGGGAGGCAAGACTATAAGTT-3′ 5′-TTTAGTGAAGGATTCATGTAACT-3′
13 5′-CTAATATTTTACTAAAACAGGCAG-3′ 5′-CACCATTGCTTTCCAATGCGAGA-3′
14 5′-GGATACAGCACTACCTCCTCATCGC-3′ 5′-CGGCCATGCTGATGTGAGCTCTGGGT-3′
15 5′-TCAGTGTTGTCATGTTTCGGGGT-3′ 5′-GAAGTGGAATTTTTCTTCAAGCA-3′
16 5′-GAACTGATGTTAAAACTCGCCA-3′ 5′-ACCTCCCAAAGTGCTGGGATT-3′
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1651between D10S570 and D10S191 was linked to the pathogenic
gene. Allele-sharing analysis among the affected members in
the family excluded linkage with the 2 loci other than those
on  10p15–14  (Figure  3  and  Table  3).Bi-directional
sequencing  was  performed  on  all  samples  from  affected
patients and also from the controls. The sequencing results (in
reverse direction) were in conformity with those in forward
direction.  The  sequence  results  showed  that  in  affected
individuals III:2, III:7, IV:1, IV:2, IV:4, V:1, and V:2, an
‘AAA’ to ‘GAA’ transition at codon 322 of OPTN exon 10
was  observed  (See  Figure  4).  That  is  to  say,  a  missense
mutation A1274G in exon 10 of OPTN was identified in
affected patients of the family. The corresponding amino acid
change (codon number is 322) was lysine to glutamate (or
glutamic acid). This novel mutation was not found in DNA
from  unaffected  family  members  nor  in  DNA  of  the  87
unrelated normal controls.
DISCUSSION
Epidemiology studies suggest that glaucoma is one of the
leading  causes  of  visual  loss  worldwide  with  about  one
hundred million patients affected and a prevalence rate of
approximately 2% of the population older than 40 years of age
[5].  In  1993,  Sheffield  and  colleagues  [6]  undertook
successful linkage analysis of DNA specimens from JOAG
patients  by  applying  small  tandem  repeat  fragments  (the
correlated disease gene was localized in the region between
D1S194  and  D1S218  of  chromosome  1).  In  1997,  Stone
screened  the  candidate  genes  and  ascertained  the  correct
identity of the MYOC gene (i.e., previously known as TIGR).
In 1998, Sarfarazi and his team [7] performed genetic
scanning  on  glaucoma  family  members  with  NTG,  and
localized the causative gene to the region between D10S1729
and D10S1664 of 10p15–14. In 2002, Rezaie and collegues
Figure 2. PCR products of OPTN exon 10. The PCR product is 260
bp in size (lanes 1-11). Lane M is the DL2000 marker.
[3]  found  that  coding  amino  acid  alterations  consisted  of
mistranslation mutations in the OPTN gene.
At present, there are more than 20 mutations found in the
OPTN coding region, four of which have close correlation
with POAG. These mutations are respectively E50K of exon
4, M98K of exon 5, discontinuous protein coding of exon 6
and R545Q of exon 16 [3]. To our knowledge, this study
describes the first report of a Lys322Glu mutation in exon 10
of OPTN. In this case, an AAA to GAA transformation at
codon 1,274 in exon 10 causes an amino acid change from
lysine  to  glutamic  acid,  with  potential  effects  on  protein
structure and function.
OPTN  (GenBank:  AF420371,  AF420372,  and
AF420373)  is  located  on  chromosome  10p15–14,  and
includes 3 non-coding exons and 13 coding exons, which are
expressed in many tissues such as heart, brain, liver, skeletal
muscles,  kidney,  especially  in  trabecular  reticulum,  non-
colorant ciliary epithelium, and the retina. Optineurin, the 577
amino acid protein of OPTN, also called optic neuropathy
inducing protein (OPTN), is a secreted protein located in the
golgiosome. This protein is abundant in leucine zipper and
latent  zinc  fingers  formed  by  lysine-histidine-lysine.
Optineurin has an effect on activating transcription factor IIIA
(ATF) and Huntington, and participates the signal conveying
of TNF2α. Thus, it is speculated that this protein activates
apoptosis. The effectiveness of optineurin may be concerned
with the conservation of optical nerves and the maintenance
Figure 3. The haplotype atlas of the familial primary open angle
glaucoma family. Solid squares mean male patients, open circles
mean  normal  females,  solid  circles  mean  female  patients,  open
squares mean normal males.
TABLE 3. LINKAGE ANALYSIS OF AFFECTED SUBJECTS.
Marker Affected pedigree member LOD score Affected sib-pair p value
D10S570 2.086101 0.004815
D10S191 1.971699 0.0075584
Molecular Vision 2009; 15:1649-1654 <http://www.molvis.org/molvis/v15/a176> © 2009 Molecular Vision
1652of intraocular tension. Consequently, it is concluded that in
glaucomatous optic neuropathy, the decrease in optineurin
may lead to glaucomatous defects of field vision and optic
neuropathy.
The  characteristics  of  the  patients  of  this  family:  1)
autosomal dominant hereditary; 2) intraocular pressure during
attack is more than 21 mmHg; 3) the patients have marked
glaucoma optic disc, typical defect of visual field, and open
angle of anterior chamber; 4) the age when attack occurs in
the family members is inclined to be younger (the attack to
III:2 was at the age of 64, the attack to IV:1 was at the age of
44, and the attack to V:1 was at the age of 22; 5) and the disease
develops rapidly; 6) clinical therapeutic efficacy is relatively
good: after the trabeculectomy, the range of defect of visual
field  decreases  and  intraocular  pressure  is  within  normal
limits.  In  this  family,  all  patients  have  a  mutation  of
Lys322Glu, and at present patient V:2 has not been diagnosed
with  POAG.  Patient  V:2  also  has  this  mutation,  but  the
binocular visual acuity is lower than 0.6 after rectification, the
nasal side disc of the left eye ground is narrowing, and the
intraocular pressure and visual field are normal. Therefore a
timed follow-up visit is necessary to observe the development
of disease. The missense amino acid mutation could result in
the alteration of protein structure and function, and influence
the zinc finger structure, protein polarity and hydrophilicity,
and protein transportation in cells, thus influencing protein
function. This is our prediction, and we want to confirm the
prediction with follow up research, which we are doing now.
In conclusion, our investigations indicate that a novel
Lys322Glu mutation in OPTN is associated with POAG in a
large family pedigree from northeastern China. Based on our
analysis,  an  autosomal  dominance  inheritance  pattern  is
present. Further studies will be needed to investigate the effect
of this single base mutation on protein structure and function
in this cohort of patients.
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